Skip to main content
International Journal of Clinical and Experimental Medicine logoLink to International Journal of Clinical and Experimental Medicine
. 2015 Jul 15;8(7):10825–10834.

Fish consumption doesn’t reduce the risk of hepatocellular carcinoma

Cheng-Bao Wang 1, Qing-Xia Fu 2, Hai-Yan Liu 3, Rui Wang 3
PMCID: PMC4565259  PMID: 26379876

Abstract

Background: Several observational studies have investigated the association between fish consumption and the risk of hepatocellular carcinoma (HCC), however, the results were inconsistent. Hence, we performed a meta-analysis of observational studies to evaluate the effect of fish consumption on HCC risk. Methods: A systematic search was performed using the Pubmed, Embase, and Cochrane Library Central database for case-control and coshort studies that assessed fish intake and HCC risk. Fixed-effect and random-effect models were used to estimate summary relative risks (RR) and the corresponding 95% confidence intervals (CIs). Subgroup analyses and sensitivity analysis were also performed. Results: Nine case-control studies and three cohort studies were included, involving a total of 1,071,458 participants and 2,627 HCC cases. Meta-analysis showed that there was no association between fish consumption and a significant reduction in HCC incidence (RR = 0.85, 95% CI [0.62, 1.17]). In our subgroup analyses, the result was substantially affected by adjustment for hepatic viruses’ infection status. Sensitivity analysis confirmed the stability of results. Furthermore, there was no evidence of publication bias as suggested by Begg’s P value (P = 0.411) and Egger’s (P = 0.596) test. Conclusions: In conclusion, our results do not support a significant inverse association of fish consumption with HCC risk. More in-depth studies are warranted to report more detailed results, including stratified results by fish types, preparation methods, and gender.

Keywords: Fish, hepatocellular carcinoma, dietary, epidemiology, meta-analysis

Introduction

Liver cancer is the sixth most commonly diagnosed cancer and the third most common cause of cancer-related deaths worldwide [1]. In 2008, about 750,000 liver cancers were reported worldwide, with about 700,000 deaths [2,3]. Hepatocellular carcinoma (HCC) is the main type of liver cancer, accounting for over 90% of cases worldwide [3]. The established risk factors of HCC are hepatitis B and C (HBV/HCV) virus infection, aflatoxin exposure, tobacco smoking, and alcohol abuse accompanied by liver cirrhosis [4-10]. Although diet is an important factor in the development of HCC, the role of diet in the etiology of HCC remains unclear, except with regard to alcohol consumption and aflatoxin contamination. Fish is a rich source of n-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) [11-13]. Previous studies have shown that fish consumption was linked favorably or unfavorably to the risk of several cancers [14-21]. There are several case-control and prospective cohort studies investigating the association between fish intake and HCC risk, however, the results were inconsistent. To our knowledge, there has been no comprehensive quantitative assessment of the association between fish intake and HCC incidence. Hence, we performed a meta-analysis of observational studies to evaluate the effect of fish consumption on the risk of developing HCC.

Methods

Study identification

This meta-analysis was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines (PRISMA) [22], and the meta-analysis of observational studies in epidemiology (MOOSE) guidelines [23]. A literature search was carried out using Pubmed (1966 to May 2013), Embase (1947 to May 2013), and Cochrane Library Central database (1967 to May 2013). There were no restriction of origin and languages. Search terms included: “fish” or “seafood” and “cancer” or “neoplasm” or “malignancy” and “hepatocellular” or “liver”. The reference lists of each comparative study included in this meta-analysis and previous reviews were manually examined to identify additional relevant studies.

Study selection

Two reviewers independently selected eligible case-control and cohort studies that investigated fish intake and HCC risk. Disagreement between the two reviewers was settled by discussing with the third reviewer. Inclusion criteria were: (i) used a case-control or cohort study design; (ii) evaluated the association between fish intake and HCC risk; (iii) presented odds ratio (OR), relative risk (RR), or hazard ratio (HR) estimates with its 95% confidence interval (CI). Exclusion criteria: (i) the study was review article, case report, letter to the editor or editor comment; (ii) have no available data; (iii) follow-up less than one year. When there were multiple publications from the same population, only data from the most recent report were included in the meta-analysis and the remaining were excluded. Studies reporting different measures of RR like risk ratio, rate ratio, hazard ratio, and odds ratio were included in the meta-analysis. In practice, these measures of effect yield a similar estimate of RR, since the absolute risk of HCC is low.

Data extraction

The following data was collected by two reviewers independently using a purpose-designed form: name of first author, publishing time, country of the population studied, study design, study period, number of cancer cases and subjects, dietary assessment method, type of fish, quantity of intake, the study-specific adjusted ORs, RRs, or HRs with their 95% CIs for the highest category of fish consumption versus the lowest, confounding factors for matching or adjustments.

Methodological quality assessment

We used Newcastle-Ottawa scale to assess the methodologic quality of cohort and case-control studies. The Newcastle-Ottawa Scale contains eight items that are categorized three categories: selection (four items, one star each), comparability (one item, up to two stars), and exposure/outcome (three items, one star each). A “star” presents a “high-quality” choice of individual study. With consideration that there is a correlation between caloric intake and nutrient consumption, and possibly a direct or indirect causal relation between caloric intake and HCC risk, the scoring system was modified by adding an item in which a study with data analysis that used an energy-adjusted residual or nutrient-density model received an additional Star [24]. Hence, the full score was 10 stars, and the high-quality study was defined as a study with ≥ 7 awarded stars.

Data synthesis and analysis

Heterogeneity was assessed using the Cochran Q and I2 statistics. For the Q statistic, a P value < 0.10 was considered statistically significant for heterogeneity; for the I2 statistic, heterogeneity was interpreted as absent (I2: 0%-25%), low (I2: 25.1%-50%), moderate (I2: 50.1%-75%), or high (I2: 75.1%-100%) [25]. Some studies presented individual risk estimates according to the different types of fish and did not report the effect of total fish consumption. In this situation, the study-specific effect size in overall analysis was calculated by pooling the risk estimates of the various fish types, using the inverse-variance method. Subgroup analyses were carried out according to (i) study quality, (ii) study design (cohort versus case-control studies), (iii) geographic location (Europe versus Asia versus North America), (iv) number of adjustment factors (n ≥ 7 versus n ≤ 6), adjustment for hepatitis viruses infection (yes, no), adjustment for alcohol intake (yes, no), adjustment for smoking status (yes, no), adjustment for body mass index (BMI) (yes, no). Pooled RR estimates and corresponding 95% CIs were calculated using the inverse variance method. When substantial heterogeneity was detected(I2 ≥ 50%), the summary estimate based on the random-effect model (DerSimonian-Laird method) [26] was reported, which assumes that the studies included in the meta-analysis had varying effect sizes. Otherwise, the summary estimate based on the fixed-effect model (the inverse variance method) [27] was reported, which assumes that the studies included in the meta-analysis had the same effect size. We carried out sensitivity analyses by excluding one study at a time to explore whether the results were strongly influenced by a specific study. To better investigate the possible sources of between-study heterogeneity, a meta-regression analysis was performed [28]. Publication bias was assessed using Begg and Mazumdar adjusted rank correlation test and the Egger regression asymmetry test [29,30]. All analyses were performed using Stata version 11.0 (StataCorp, College Station, TX).

Results

Literature search and study characteristics

The results of the literature search are shown in Figure 1. A total of 4,061 citations were identified during the initial search. On the basis of the title and abstract, we identified 21 papers. After detailed evaluation, nine studies were excluded. At last, the remaining 12 studies published between 1982 and 2013 were included in the meta-analysis, involving a total of 2,627 HCC cases and 1,071,458 participants. Of these 12 studies, one was population-based case-control studies [31], eight were hospital-based case-control studies [32-39], and the remaining three were cohort studies [40-42]. Six studies were conducted in Asia [31,35-37,39,41], five in Europe [32-34,38,40], and the remaining one in North America [42]. Most studies used food frequency questionnaires (FFQ) for the assessment of fish consumption (Baseline data and other details are shown in Table 1). Table S1 summarizes the quality scores of cohort studies and case-control studies. The Newcastle-Ottawa Scale scores for the included studies ranged from 5 to 10, with a median 7.5. The median scores of cohort studies and case-control studies were 9 and 7, respectively. 8 studies (66.6%) were deemed to be of a high quality (≥ 7).

Figure 1.

Figure 1

Flow diagram of screened, excluded, and analyzed publications.

Table 1.

Characteristics of studies included in the present meta-analysis

Author Publication year Country Study design Study period Sex Methods used for dietary assessment Cases/Subjects Type of fish Units and comparison groups Confounders for adjustment
Fedirko V 2013 Western Europe cohort study 1992-2010 M/F country-specific, validated dietary questionnaires 191/477,206 Total fish Q4 vs Q1 smoking status, physical activity level, diabetes status, lifetime alcohol intake pattern, BMI, baseline intakes of coffee, alcohol, meat, and dietary fiber
Sawada N 2012 Japan cohort study 1990-1994 M/F FFQ 138 items 398/90,296 Total fish High vs low age, area, sex, HCV, HBsAg, ALT level, smoking status, alcohol frequency, BMI, past history of diabetes mellitus, and intake of coffee, soy foods, vegetables, vegetable oil, protein, and iron
Daniel CR 2011 USA cohort study 1995–1996 M/F FFQ 124 items 582/492,186 Total fish Q5 vs Q1 meat intake, age, sex, education, marital status, family history of cancer, race, BMI, smoking status, frequency of vigorous physical activity, menopausal hormone therapy in women, intake of alcohol, fruit, vegetables, and total energy
Kanazir M 2010 Serbia hospital based case-control study 2004-2007 M/F standard questionnaire 13 main food groups or food items 45/135 Total fish Weekly vs rarely gender and age
Talamini R 2006 Italy hospital based case-control study 1999–2002 M/F FFQ 63 items 185/597 Total fish 4Q vs 1Q gender, age, centre, education, place of birth, drinking habits, maximal lifetime alcohol intake, hepatitis viruses, and total energy intake
Yu S 2002 China population based case-control study 1995-1997 M/F interviewer-administered questionnaire 248/496 Salted fish, fresh fish High vs low age, sex, residence, and HBV
Fernandez E 1999 Italy hospital based case-control study 1983-1996 M/F FFQ 37 items 428/8,418 Total fish Servings/week ≥ 2 vs < 1 age, sex, area of residence, education, smoking, alcohol consumption, and BMI
Wang ZJ 1996 China hospital based case-control study 1994-1995 M/F FFQ 91 items 96/240 Salted fish, fresh fish High vs low age, sex, HCV, HBsAg, occupation, education, income, alcohol consumption, history of liver disease, history of hepatitis, pickles intake
Srivatanakul P 1991 Thailand hospital based case-control study 1987-1988 M/F FFQ 11 items 65/130 Fermented fish Servings/day ≥ 3 vs < 3 age and educational level
Lu SN 1988 China hospital based case-control study 1985 M/F standardized questionnaire 131/338 Raw fish Occasional vs never age, sex and hepatitis B surface antigen
La Vecchia C 1988 Italy hospital based case-control study 1984-1987 M/F FFQ 14 items 151/1,202 Total fish High vs low none
Lam KC 1982 China hospital based case-control study 1977-1980 M/F FFQ 14 items 107/214 Salted fish Daily vs less than weekly none

M: male; F: female; BMI: body mass index; FFQ = food frequency questionnaire.

Main analysis

Because of significant heterogeneity (I2 = 75.1%, P < 0.001) was observed, a random-effects model was chosen over a fixed-effects model and we found that there was no association between fish consumption and a significant reduction in HCC incidence (RR = 0.85, 95% CI [0.62, 1.17]). Both multivariable adjusted RR estimates with 95% CIs of each study and combined RR is shown in Figure 2.

Figure 2.

Figure 2

Forest plot: overall meta-analysis of fish consumption and HCC risk. Squares indicated study-specific risk estimates (size of square reflects the study-statistical weight, i.e. inverse of variance); horizontal lines indicate 95% confidence intervals; diamond indicates summary relative risk estimate with its corresponding 95% confidence interval.

Subgroup analyses and sensitivity analysis

We found a significant association between fish intake and decreased HCC risk among cohort studies (RR = 0.74, 95% CI [0.55, 0.98]), however, there was no significant association between fish intake and HCC risk among case-control studies (RR = 0.92, 95% CI [0.59, 1.43]), presented in Table 2. When stratified the various studies by geographic location, no significant association was noted among studies conducted in Europe (RR = 0.75, 95% CI [0.53, 1.06]), Asian (RR = 0.96, 95% CI [0.46, 2.01]), and North America (RR = 0.86, 95% CI [0.65, 1.13]). When we examined whether the associations differed by adjustment for BMI, alcohol intake, and smoking status, the associations did not vary by these factors (shown in Table 2). However, the associations varied significantly by adjustment for hepatitis viruses infection status. No significant association was noted among studies which adjusted for hepatitis viruses infection status (RR = 1.11, 95% CI [0.50, 2.46]), while a significant inverse association was found among studies which haven’t adjusted for hepatitis viruses infection status (RR = 0.76, 95% CI [0.60, 0.96]). Further, it was observed that studies with higher control for potential confounders (n ≥ 7) as well as studies with lower control (n ≤ 6) presented no significant association between fish intake and reduced HCC risk (RR = 1.00, 95% CI [0.66, 1.52] and RR = 0.69, 95% CI [0.42, 1.14], respectively) (shown in Table 2). When we did subgroup analysis of high-quality studies, we found there was no significant association between fish intake and reduced HCC risk (RR = 0.84, 95% CI [0.63, 1.13]). To test the robustness of association and characterize possible sources of statistical heterogeneity, sensitivity analyses were carried out by excluding studies one-by-one and analyzing the homogeneity and effect size for all of rest studies. Sensitivity analysis indicated that no significant variation in combined RR by excluding any of the study, confirming the stability of present results.

Table 2.

Subgroup analysis of fish intake and the risk of hepatocellular carcinoma

No. of studies Pooled estimate Tests of heterogeneity

RR 95% CI P value I2 (%)
All studies 12 0.85 0.62-1.17 < 0.001 75.10
High-quality studies (scores ≥ 7) 8 0.84 0.63-1.13 0.11 44.60
Study design
    Cohort 3 0.74 0.55-0.98 0.29 19.50
    Case-control 9 0.92 0.59-1.43 < 0.001 79.20
Geographic location
    Europe 5 0.75 0.53-1.06 0.08 51.50
    Asia 6 0.96 0.46-2.01 < 0.001 84.70
    North America 1 0.86 0.65-1.13 / /
Adjusted for confounders
Number of adjustment factors
    n ≥ 7 confounders 6 1.00 0.66-1.52 < 0.001 80.40
    n ≤ 6 confounders 6 0.69 0.42-1.14 0.01 64.80
Major confounders adjusted
BMI
    Yes 4 0.81 0.64-1.04 0.22 32.00
    No 8 0.90 0.51-1.58 < 0.001 81.80
Alcohol
    Yes 6 1.00 0.66-1.52 < 0.001 80.40
    No 6 0.69 042-1.14 0.01 64.80
Smoking status
    Yes 4 0.81 0.64-1.04 0.22 32.00
    No 8 0.90 0.51-1.58 < 0.001 81.80
Hepatitis viruses infection
    Yes 5 1.11 0.50-2.46 < 0.001 85.80
    No 7 0.76 0.60-0.96 0.15 36.10
Processed fish 4 0.94 0.46-1.93 0.03 67.50

RR = relative risks; CI = confidence intervals.

Meta-regression analysis

To better investigate the possible sources of between-study heterogeneity, a meta-regression analysis was performed. Study design, geographic location, number of adjustment factors, adjustment for hepatitis viruses infection, adjustment for alcohol intake, adjustment for smoking status, adjustment for BMI, which may be potential sources of heterogeneity, were tested by a meta-regression method. Meta-regression analysis revealed that study design (P = 0.039) was the source of heterogeneity.

Publication bias

In the present meta-analysis, no publication bias was observed among studies using Begg’s P value (P = 0.411); Egger’s (P = 0.596) test, which suggested there was no evidence of publication bias (Figure 3).

Figure 3.

Figure 3

Funnel plot for publication bias in the studies investigating risk for HCC associated with fish intake.

Discussion

To our knowledge, this is the first meta-analysis evaluating the association between fish intake and HCC risk. The present meta-analysis included 12 observational studies currently available (three cohort studies and nine case-control studies), involving a total of 1,071,458 participants and 2,627 HCC cases. There was statistically significant heterogeneity among the 12 included studies investigating the association between fish consumption and HCC risk, so a random-effects model was chosen over a fixed-effects model. Finally, we found that there was no association between fish consumption and a significant reduction in HCC incidence (comparing the highest with the lowest category). Sensitivity analysis indicated that an omission of any studies did not alter the magnitude of observed effect, suggesting a stability of our findings. Moreover, the results of Begg’s test and Egger’s test did not support the existence of major publication bias.

As we know, fish oil is rich source of n-3 fatty acids. Previous animal model studies have shown that n-3 polyunsaturated fatty acids were linked to the reduction of the progression of cancer cells [43,44]. Multiple mechanisms are involved in this chemopreventive activity, including suppression of neoplastic transformation, cell growth inhibition and enhanced apoptosis, and antiangiogenicity [45-47]. Although inverse association between fish intake and risk of HCC is biologically plausible, our result showed a null association. In the present meta-analysis, most of the studies were case-control studies. Our findings from the case-control studies suggested a nonsignificant reduction between fish intake and HCC risk, but the results from the prospective cohort studies showed a statistically significant inverse association. Compared with retrospective case-control studies, prospective cohort studies are less susceptible to bias (e.g. recall bias, selection bias) due to their nature. Furthermore, case-control studies had a lower median quality score than cohort studies (7 versus 9). So, the association may be changed by poor study methodologies. In addition, we should notice that there were only three cohort studies investigating the association between fish intake and the risk of HCC. That number is rather low to draw firm conclusions. So more prospective cohort studies are needed to confirm the association between fish consumption and risk of HCC in the future.

Most of the studies reporting the associations of fish with risk of HCC were primarily designed to study either the effect of meat or a variety of risk factors. Thus, they focused on total fish rather than different species of fish or different preparation methods. This limitation might contribute to the null findings in the primary studies and this meta-analysis. Fish can be served in many ways, such as fresh, broiled, baked, salted, or fried. Fish preparation methods may alter the relation between fish intake and HCC by changing the lipid profile and by generating unexpected chemicals with the use of certain cooking methods. Frying, in particular, was found to considerably reduce the amount of long-chain (n-3) PUFA (LC-PUFA) in fish [48]. Deep-frying could generate trans-fatty acids, oxidized lipids, or food mutagens such as heterocyclic amines and benzo (a) pyrene, which may promote carcinogenesis and which was found to be associated with elevated cancer risk [49]. Salted fish are rich in chemical carcinogens, such as nitrites, heterocyclic amines, 2-chloro-4-methylthiobutanoic acid, and so on, which may be associated with increased risk of cancer [50,51]. There were four studies [31,35,36,39] investigating processed fish and HCC risk, however, the results of meta-analysis haven’t shown a significant association between processed fish intake and increased HCC risk. We think there are several reasons which may lead to the null association. Firstly, all the four studies were retrospective case-control studies. Secondly, three of the four studies have adjusted few confounders (n ≤ 4). Thirdly, we should notice that there were only four studies investigating the association between processed fish intake and HCC risk, that number is rather low to draw firm conclusion. So more prospective cohort studies with well controlled confounding factors are needed to confirm the association between processed fish consumption and risk of HCC.

The strength of the present meta-analysis lies in a large sample size (2,627 HCC cases and 1,071,458 participants) and no significant evidence of publication bias. Two investigators independently performed the article identification, data extraction,

and verification and resolved all discrepancies. Furthermore, our findings were stable and robust in sensitivity analyses. However, several limitations to this meta-analysis should be noted. Firstly, as a meta-analysis of observational data, the possibility of recall and selection biases cannot be ruled out. Compared with case-control studies, cohort studies are less susceptible to bias due to their nature. However, the present meta-analysis included only three cohort studies, so more prospective cohort studies are need to confirm the association in the future. Secondly, we did not search for unpublished studies, so only published studies were included in our meta-analysis. Therefore, publication bias may have occurred although no publication bias was indicated from both visualization of the funnel plot and Egger’s test. Thirdly, most of the included studies haven’t adjusted for hepatitis B and C virus infection, aflatoxin exposure, tobacco smoking, and alcohol abuse accompanied by liver cirrhosis, which are associated with increased risk of HCC. Fourthly, all of the included studies didn’t reported results separately for males and females, and we can’t do subgroup analysis according to gender. So, future studies should reported results separately for males and females. Lastly, different types of fish (lean fish and fatty fish, fresh fish and processed fish) may have different effects on the risk of HCC, however, we can’t do detailed meta-analysis for a lack of data. Although we assessed processed fish and the risk of HCC, the number of included studies is rather low to draw firm conclusion.

In conclusion, the present meta-analysis suggests that there was no association between fish consumption and a significant reduction in HCC incidence. More in-depth studies are warranted to report more detailed results, including stratified results by fish type, preparation methods, and gender.

Disclosure of conflict of interest

None.

Supporting Information

ijcem0008-10825-f4.pdf (212KB, pdf)

References

  • 1.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi: 10.3322/caac.20107. [DOI] [PubMed] [Google Scholar]
  • 2.El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. doi: 10.1053/j.gastro.2007.04.061. [DOI] [PubMed] [Google Scholar]
  • 3.Gomes MA, Priolli DG, Tralhao JG, Botelho MF. Hepatocellular carcinoma: Epidemiology, biology, diagnosis, and therapies. Rev Assoc Med Bras. 2013;59:514–24. doi: 10.1016/j.ramb.2013.03.005. [DOI] [PubMed] [Google Scholar]
  • 4.Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127:S72–78. doi: 10.1016/j.gastro.2004.09.018. [DOI] [PubMed] [Google Scholar]
  • 5.Wong GL, Chan HL, Yiu KK, Lai JW, Chan VK, Cheung KK, Wong EW, Wong VW. Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma. Aliment Pharmacol Ther. 2013;37:517–526. doi: 10.1111/apt.12207. [DOI] [PubMed] [Google Scholar]
  • 6.Villa E, Melegari M, Scaglioni PP, Trande P, Cesaro P, Manenti F. Hepatocellular carcinoma: risk factors other than HBV. Ital J Gastroenterol. 1991;23:457–460. [PubMed] [Google Scholar]
  • 7.Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1413–1421. e1. doi: 10.1016/j.cgh.2013.04.039. [DOI] [PubMed] [Google Scholar]
  • 8.Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130:1639–1648. doi: 10.1002/ijc.26165. [DOI] [PubMed] [Google Scholar]
  • 9.Liu Y, Chang CC, Marsh GM, Wu F. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer. 2012;48:2125–2136. doi: 10.1016/j.ejca.2012.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:1261–1268. doi: 10.1158/1055-9965.EPI-09-1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Anderson BM, Ma DW. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009;8:33. doi: 10.1186/1476-511X-8-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Merendino N, Costantini L, Manzi L, Molinari R, D’Eliseo D, Velotti F. Dietary omega -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer. Biomed Res Int. 2013;2013:310186. doi: 10.1155/2013/310186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lorente-Cebrian S, Costa AG, Navas-Carretero S, Zabala M, Martínez JA, Moreno-Aliaga MJ. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem. 2013;69:633–651. doi: 10.1007/s13105-013-0265-4. [DOI] [PubMed] [Google Scholar]
  • 14.Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–1233. doi: 10.3945/ajcn.2010.29530. [DOI] [PubMed] [Google Scholar]
  • 15.Salehi M, Moradi-Lakeh M, Salehi MH, Nojomi M, Kolahdooz F. Meat, fish, and esophageal cancer risk: a systematic review and dose-response meta-analysis. Nutr Rev. 2013;71:257–267. doi: 10.1111/nure.12028. [DOI] [PubMed] [Google Scholar]
  • 16.Li Z, Yu J, Miao Q, Sun S, Sun L, Yang H, Hou L. The association of fish consumption with bladder cancer risk: a meta-analysis. World J Surg Oncol. 2011;9:107. doi: 10.1186/1477-7819-9-107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Han YJ, Li J, Huang W, Fang Y, Xiao LN, Liao ZE. Fish consumption and risk of esophageal cancer and its subtypes: a systematic review and meta-analysis of observational studies. Eur J Clin Nutr. 2013;67:147–154. doi: 10.1038/ejcn.2012.213. [DOI] [PubMed] [Google Scholar]
  • 18.Wu S, Feng B, Li K, Zhu X, Liang S, Liu X, Han S, Wang B, Wu K, Miao D, Liang J, Fan D. Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med. 2012;125:551–9.e5. doi: 10.1016/j.amjmed.2012.01.022. [DOI] [PubMed] [Google Scholar]
  • 19.Kolahdooz F, van der Pols JC, Bain CJ, Marks GC, Hughes MC, Whiteman DC, Webb PM Australian Cancer Study (Ovarian Cancer) and the Australian Ovarian Cancer Study Group. Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr. 2010;91:1752–1763. doi: 10.3945/ajcn.2009.28415. [DOI] [PubMed] [Google Scholar]
  • 20.Qin B, Xun P, He K. Fish or long-chain (n-3) PUFA intake is not associated with pancreatic cancer risk in a meta-analysis and systematic review. J Nutr. 2012;142:1067–1073. doi: 10.3945/jn.111.156711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zheng JS, Hu XJ, Zhao YM, Yang J, Li D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ. 2013;346:f3706. doi: 10.1136/bmj.f3706. [DOI] [PubMed] [Google Scholar]
  • 22.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341. doi: 10.1016/j.ijsu.2010.02.007. [DOI] [PubMed] [Google Scholar]
  • 23.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012. doi: 10.1001/jama.283.15.2008. [DOI] [PubMed] [Google Scholar]
  • 24.Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S. doi: 10.1093/ajcn/65.4.1220S. discussion 1229S-1231S. [DOI] [PubMed] [Google Scholar]
  • 25.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  • 27.Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  • 28.Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23:1663–1682. doi: 10.1002/sim.1752. [DOI] [PubMed] [Google Scholar]
  • 29.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. [PubMed] [Google Scholar]
  • 31.Yu SZ, Huang XE, Koide T, Cheng G, Chen GC, Harada K, Ueno Y, Sueoka E, Oda H, Tashiro F, Mizokami M, Ohno T, Xiang J, Tokudome S. Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China. Jpn J Cancer Res. 2002;93:1287–1292. doi: 10.1111/j.1349-7006.2002.tb01236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kanazir M, Boricic I, Delic D, Tepavcevic DK, Knezevic A, Jovanovic T, Pekmezovic T. Risk factors for hepatocellular carcinoma: a case-control study in Belgrade (Serbia) Tumori. 2010;96:911–917. [PubMed] [Google Scholar]
  • 33.Talamini R, Polesel J, Montella M, Dal Maso L, Crispo A, Tommasi LG, Izzo F, Crovatto M, La Vecchia C, Franceschi S. Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy. Int J Cancer. 2006;119:2916–2921. doi: 10.1002/ijc.22267. [DOI] [PubMed] [Google Scholar]
  • 34.Fernandez E, Chatenoud L, La Vecchia C, Negri E, Franceschi S. Fish consumption and cancer risk. Am J Clin Nutr. 1999;70:85–90. doi: 10.1093/ajcn/70.1.85. [DOI] [PubMed] [Google Scholar]
  • 35.Wang ZJ, Zhou YP, Cheng B. [An epidemiologic study on the aetiological factors of primary liver cancer in Shunde City of Guangdong province] . Zhonghua Liu Xing Bing Xue Za Zhi. 1996;17:141–144. [PubMed] [Google Scholar]
  • 36.Srivatanakul P, Parkin DM, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L’Abbé KA, Wild CP. Liver cancer in Thailand. II. A case-control study of hepatocellular carcinoma. Int J Cancer. 1991;48:329–332. doi: 10.1002/ijc.2910480303. [DOI] [PubMed] [Google Scholar]
  • 37.Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer. 1988;62:2051–2055. doi: 10.1002/1097-0142(19881101)62:9<2051::aid-cncr2820620930>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 38.La Vecchia C, Negri E, Decarli A, D’Avanzo B, Franceschi S. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer. 1988;42:872–876. doi: 10.1002/ijc.2910420614. [DOI] [PubMed] [Google Scholar]
  • 39.Lam KC, Yu MC, Leung JW, Henderson BE. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res. 1982;42:5246–5248. [PubMed] [Google Scholar]
  • 40.Fedirko V, Trichopolou A, Bamia C, Duarte-Salles T, Trepo E, Aleksandrova K, Nöthlings U, Lukanova A, Lagiou P, Boffetta P, Trichopoulos D, Katzke VA, Overvad K, Tjønneland A, Hansen L, Boutron-Ruault MC, Fagherazzi G, Bastide N, Panico S, Grioni S, Vineis P, Palli D, Tumino R, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Engeset D, Parr CL, Jakszyn P, Sánchez MJ, Barricarte A, Amiano P, Chirlaque M, Quirós JR, Sund M, Werner M, Sonestedt E, Ericson U, Key TJ, Khaw KT, Ferrari P, Romieu I, Riboli E, Jenab M. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC) Ann Oncol. 2013;24:2166–73. doi: 10.1093/annonc/mdt168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sawada N, Inoue M, Iwasaki M, Sasazuki S, Shimazu T, Yamaji T, Takachi R, Tanaka Y, Mizokami M, Tsugane S Japan Public Health Center-Based Prospective Study Group. Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology. 2012;142:1468–1475. doi: 10.1053/j.gastro.2012.02.018. [DOI] [PubMed] [Google Scholar]
  • 42.Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila) 2011;4:1903–1911. doi: 10.1158/1940-6207.CAPR-11-0241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hilakivi-Clarke L, Olivo SE, Shajahan A, Khan G, Zhu Y, Zwart A, Cho E, Clarke R. Mechanisms mediating the effects of prepubertal (n-3) polyunsaturated fatty acid diet on breast cancer risk in rats. J Nutr. 2005;135:2946S–2952S. doi: 10.1093/jn/135.12.2946S. [DOI] [PubMed] [Google Scholar]
  • 44.Ford JH. Saturated fatty acid metabolism is key link between cell division, cancer, and senescence in cellular and whole organism aging. Age (Dordr) 2010;32:231–237. doi: 10.1007/s11357-009-9128-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr. 2007;137:200S–204S. doi: 10.1093/jn/137.1.200S. [DOI] [PubMed] [Google Scholar]
  • 46.Stoll BA. N-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br J Nutr. 2002;87:193–198. doi: 10.1079/BJNBJN2001512. [DOI] [PubMed] [Google Scholar]
  • 47.Cerchietti LC, Navigante AH, Castro MA. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer. 2007;59:14–20. doi: 10.1080/01635580701365068. [DOI] [PubMed] [Google Scholar]
  • 48.Echarte M, Zulet MA, Astiasaran I. Oxidation process affecting fatty acids and cholesterol in fried and roasted salmon. J Agric Food Chem. 2001;49:5662–5667. doi: 10.1021/jf010199e. [DOI] [PubMed] [Google Scholar]
  • 49.Skog K. Cooking procedures and food mutagens: a literature review. Food Chem Toxicol. 1993;31:655–675. doi: 10.1016/0278-6915(93)90049-5. [DOI] [PubMed] [Google Scholar]
  • 50.Skog KI, Johansson MA, Jagerstad MI. Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. Food Chem Toxicol. 1998;36:879–896. doi: 10.1016/s0278-6915(98)00061-1. [DOI] [PubMed] [Google Scholar]
  • 51.Chen W, Weisburger JH, Fiala ES, Spratt TE, Carmella SG, Chen D, Hecht SS. Gastric carcinogenesis: 2-chloro-4-methylthiobutanoic acid, a novel mutagen in salted, pickled Sanma hiraki fish, or similarly treated methionine. Chem Res Toxicol. 1996;9:58–66. doi: 10.1021/tx9500585. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ijcem0008-10825-f4.pdf (212KB, pdf)

Articles from International Journal of Clinical and Experimental Medicine are provided here courtesy of e-Century Publishing Corporation

RESOURCES